Document is current

Any future updates will be listed below

Minimalist “in situ” tumor vaccine leveraging versatile dendrimer nanoplatform coordinated ICD and immunoagonist for boosted chemoimmunotherapy

Crossref DOI link: https://doi.org/10.1007/s40843-024-2940-6

Published Online: 2024-06-14

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark